Ads
related to: when to treat pulmonary hypertension in children with cancer patients- Nitric Oxide Therapy
Treat Hypoxic Respiratory Failure &
Help Increase Neonates' O2 Levels.
- Abrupt NO Discontinuation
Help Mitigate The Risk Of Rebound
Pulmonary Hypertension With Alarms.
- Access HCP Support
Speak w/ A Representative To Learn
More About iNO Resources & Support.
- Delivery System Resources
View Our Delivery Systems Portfolio
All Equipped With Enhanced Safety.
- Nitric Oxide Therapy
Search results
Results From The WOW.Com Content Network
Chung has concentrated research efforts for cardiac disease on pulmonary arterial hypertension, inherited arrhythmias, and cardiomyopathies. [20] Chung has found four genes which cause pulmonary hypertension. [20] Chung's current research is focused on identifying genes leading to pulmonary hypertension in children. [20]
Bosentan, sold under the brand name Tracleer among others, is a dual endothelin receptor antagonist medication used in the treatment of pulmonary artery hypertension (PAH). [ 4 ] [ 5 ] Bosentan is available as film-coated tablets (62.5 mg or 125 mg) or as dispersable tablets for oral suspension (32 mg).
Winrevair was approved to treat pulmonary arterial hypertension (PAH), a progressive disorder caused by a constriction of arteries in the lungs, leading to symptoms such as shortness of breath ...
Doctors noticed, though, that she had pulmonary hypertension, a condition where the blood pressure in the lungs is high, according to the National Institutes of Health. They worried that medicine ...
Signs of pulmonary hypertension on CT scan of the chest are: Enlargement of the pulmonary trunk (measured at its bifurcation). It is, however, a poor predictor of pulmonary hypertension in patients with interstitial lung disease. [62] A diameter of more than 27 mm for women and 29 mm for men is suggested as a cutoff. [62]
Imatinib, sold under the brand names Gleevec and Glivec (both marketed worldwide by Novartis) among others, is an oral targeted therapy medication used to treat cancer. [2] Imatinib is a small molecule inhibitor targeting multiple tyrosine kinases such as CSF1R , ABL , c-KIT , FLT3 , and PDGFR-β .
Ads
related to: when to treat pulmonary hypertension in children with cancer patients